DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Q: What does CUSIP 25253X207 represent in this 13F holders report?

CUSIP 25253X207 is the security identifier for DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value used to aggregate holder disclosures.

Q: How many institutions held DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in Q2 2023?

30 institutional investors reported DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 25253X207

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Voting Common Shares, no par value
Total 13F shares: 3,490,534
Total 13F value: $15,080,277
Share change: +915,483
Put/Call ratio: 1.2%
SEC-reported price per share: $4.32
Number of holders: 30
Value change: +$4,150,477
Number of buys: 14
Number of sells: 8
Shares outstanding: 52,272,727

Security key

25253X207

Report period

Q2 2023

Institutions

Top holders

DMAC full security history Ownership snapshot Full 13F holder table DiaMedica Therapeutics Inc. SEC filings DiaMedica Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Leon G. Cooperman

Disclosed value leader

Leon G. Cooperman

Comparable rows

15/15

Latest evidence

31 Mar 2023

13F Lead comparable stake: 1.7% Showing 1-6 of 15 holder rows.

Quick read

Leon G. Cooperman leads the comparable SEC ownership view at 1.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Leon G. Cooperman's linked filing trail.

Comparable ownership Top 5

Leon G. Cooperman 1.7%

VANGUARD GROUP INC 1.5%

JACOB ASSET MANAGEMENT OF NEW YOR... 0.45%

GEODE CAPITAL MANAGEMENT, LLC 0.35%

NORTHERN TRUST CORP 0.17%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Leon G. Cooperman	13F Individual 13F	1.7%	$1,328,672 868,413 shares	—	31 Mar 2023
VANGUARD GROUP INC	13F Company 13F	1.5%	$1,197,973 782,989 shares	—	31 Mar 2023
JACOB ASSET MANAGEMENT OF NEW YORK LLC	13F Company 13F	0.45%	$357,607 233,730 shares	—	31 Mar 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.35%	$282,851 184,870 shares	—	31 Mar 2023
NORTHERN TRUST CORP	13F Company 13F	0.17%	$138,962 90,825 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	0.14%	$109,655 71,670 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,490,534

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %